Trial intelligence / Profile preview

CNAP monitoring of remimazolam tosilate vs propofol during painless gastroscopy

ChiCTR2300068901Phase 4Not yet recruiting

Sponsor
Dongguan Donghua Hospital
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of remimazolam and propofol in None and Procedural anxiety (2 arms), sponsored by Dongguan Donghua Hospital. Primary endpoints: mean arterial pressure, oxyhemoglobin saturation and 2 more. Planned start Mar 2023; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

Procedural anxiety

Beyond the preview

Go deeper on ChiCTR2300068901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300068901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call